Ghent University Academic Bibliography

Journal Article
A1
open access

Rigorous donor selection for fecal microbiota transplantation in active ulcerative colitis : key lessons from a randomized controlled trial halted for futility

Clara Caenepeel, Sara Deleu, Jorge Francisco Vazquez Castellanos, Kaline Arnauts, Sara Braekeleire, Kathleen Machiels, Filip Baert, Fazia Mana, Lieven Pouillon, Pieter Hindryckx (UGent) , et al.

(2025) CLINICAL GASTROENTEROLOGY AND HEPATOLOGY. 23(4). p.621-631.e7

Add to list

Conference Paper

OP2 - Identifying genetic markers of fibrostenosis in patients with Crohn's disease

Jade Celis (UGent) , Sofie Fouquaert (UGent) , Tom Holvoet, Deborah Jans, Peter Bossuyt, Isabelle De Kock (UGent) , Edouard Louis, Michel Georges, Séverine Vermeire, Martine De Vos (UGent) , et al.

(2024)

Add to list

Journal Article
A1
open access

HLA-DP on epithelial cells enables tissue damage by NKp44+ natural killer cells in ulcerative colitis

Martin E. Baumdick, Annika Niehrs, Frauke Degenhardt, Maria Schwerk, Ole Hinrichs, Ana Jordan-Paiz, Benedetta Padoan, Lucy H.M. Wegner, Sebastian Schloer, Britta F. Zecher, et al.

(2023) GASTROENTEROLOGY. 165(4). p.946-962

Add to list

A randomized placebo controlled clinical trial with 5-hydroxytryptophan in patients with quiescent Inflammatory Bowel Disease and fatigue (Trp-IBD)

Marie Truyens (UGent) , Triana Lobatón Ortega (UGent) , Anneleen Peeters (UGent) , Marc Ferrante, Séverine Vermeire, Peter Bossuyt, Lieven Pouillon, Pieter Dewint, Anneline Cremer, Harald Peeters, et al.

(2022) JOURNAL OF CROHNS & COLITIS. In Journal of Crohns & Colitis 16(Supplement 1). p.i029-i032

Add to list

Journal Article
A1
open access

Effect of 5-hydroxytryptophan on fatigue in quiescent inflammatory bowel disease : a randomized controlled trial

Marie Truyens (UGent) , Triana Lobatón Ortega (UGent) , Marc Ferrante, Peter Bossuyt, Séverine Vermeire, Lieven Pouillon, Pieter Dewint, Anneline Cremer, Harald Peeters, Guy Lambrecht, et al.

(2022) GASTROENTEROLOGY. 163(5). p.1294-1305.e3

Add to list

Journal Article
A1
open access

Efficacy of anti-TNF dosing interval lengthening in adolescents and young adults with inflammatory bowel disease in sustained remission (FREE-study) : protocol for a partially randomised patient preference trial

Marleen Bouhuys, Willem S Lexmond, Gerard Dijkstra, Triana Lobatón Ortega (UGent) , Edouard Louis, Stephanie Van Biervliet (UGent) , Henk Groen, Jordi Guardiola and Patrick van Rheenen

(2021) BMJ OPEN. 11(11).

Add to list

Expert consensus : practical algorithms for management of inflammatory bowel disease patients presenting with back pain or peripheral arthropathies

Gaëlle Varkas (UGent) , Clio Ribbens, Edouard Louis, Filip Van den Bosch (UGent) , Rik Lories, Severine Vermeire, Dirk Elewaut (UGent) and Martine De Vos (UGent)

(2019) ALIMENTARY PHARMACOLOGY & THERAPEUTICS. 50(11-12). p.1204-1213

Add to list

Journal Article
A1
open access

IBD risk loci are enriched in multigenic regulatory modules encompassing putative causative genes

Yukihide Momozawa, Julia Dmitrieva, Emilie Theatre, Valerie Deffontaine, Souad Rahmouni, Benoit Charloteaux, Francois Crins, Elisa Docampo, Mahmoud Elansary, Ann-Stephan Gori, et al.

(2018) NATURE COMMUNICATIONS. 9.

Add to list

Long-term outcomes with anti-TNF therapy and accelerated step-up in the prospective pediatric Belgian Crohnʼs disease registry (BELCRO)

Lucas Wauters, Françoise Smets, Elisabeth De Greef, Patrick Bontems, Ilse Hoffman, Bruno Hauser, Philippe Alliet, Wim Arts, Harald Peeters (UGent) , Stephanie Van Biervliet (UGent) , et al.

(2017) INFLAMMATORY BOWEL DISEASES. 23(9). p.1584-1591

Add to list

Genome-wide copy number variation scan identifies complement component C4 as novel susceptibility gene for Crohn's disease

Isabelle Cleynen, Peter Konings, Caroline Robberecht, Debby Laukens (UGent) , Leila Amininejad, Emilie Théâtre, Kathleen Machiels, Ingrid Arijs, Paul Rutgeerts, Edouard Louis, et al.

(2016) INFLAMMATORY BOWEL DISEASES. 22(3). p.505-515

Academic Bibliography

Rigorous donor selection for fecal microbiota transplantation in active ulcerative colitis : key lessons from a randomized controlled trial halted for futility

OP2 - Identifying genetic markers of fibrostenosis in patients with Crohn's disease

HLA-DP on epithelial cells enables tissue damage by NKp44+ natural killer cells in ulcerative colitis

A randomized placebo controlled clinical trial with 5-hydroxytryptophan in patients with quiescent Inflammatory Bowel Disease and fatigue (Trp-IBD)

Effect of 5-hydroxytryptophan on fatigue in quiescent inflammatory bowel disease : a randomized controlled trial

Efficacy of anti-TNF dosing interval lengthening in adolescents and young adults with inflammatory bowel disease in sustained remission (FREE-study) : protocol for a partially randomised patient preference trial

Expert consensus : practical algorithms for management of inflammatory bowel disease patients presenting with back pain or peripheral arthropathies

IBD risk loci are enriched in multigenic regulatory modules encompassing putative causative genes

Long-term outcomes with anti-TNF therapy and accelerated step-up in the prospective pediatric Belgian Crohnʼs disease registry (BELCRO)

Genome-wide copy number variation scan identifies complement component C4 as novel susceptibility gene for Crohn's disease

Contents

Support

Contact